tailieunhanh - Host DNA contents in fecal metagenomics as a biomarker for intestinal diseases and effective treatment

Compromised intestinal barrier (CIB) has been associated with many enteropathies, including colorectal cancer (CRC) and inflammatory bowel disease (IBD). We hypothesized that CIB could lead to increased host-derived contents including epithelial cells into the gut, change its physio-metabolic properties, and globally alter microbial community and metabolic capacities. |

TỪ KHÓA LIÊN QUAN